Gossamer Bio reported last month that its only late-stage candidate failed a Phase 3 study in pulmonary arterial hypertension, casting doubt on the asset's future prospects.

Original title: “Gossamer Nearly Halves Workforce in Savings Push After Late-Stage Hypertension Fail”

sotatercept for decompensated pulmonary arterial hypertension requiring va ecmo first canadian icu experience

Original title: “Sotatercept for Decompensated Pulmonary Arterial Hypertension Requiring VA ECMO: First Canadian ICU Experience.”

pah former transfer learning for efficient discovery of pulmonary arterial hypertension associated genes

Original title: “PAH-former: Transfer learning for efficient discovery of pulmonary arterial hypertension-associated genes.”

The deal hands GSK a drug it views as a potentially “best-in-class” therapy for blood pressure diseases like pulmonary arterial hypertension — the target of Merck’s fast-selling Winrevair.

Original title: “GSK to acquire 35Pharma in $950M deal for cardiovascular drug”

Following a disappointing Phase 3 performance and given Gossamer Bio’s balance sheet, seralutinib’s path to the market for pulmonary arterial hypertension has become unclear, according to analysts at Guggenheim Partners.

Original title: “Gossamer Nosedives as Late-Stage Failure Plunges PAH Program Into Uncertainty”

management of pulmonary arterial hypertension in systemic sclerosis from classical treatments to new horizons

Original title: “Management of pulmonary arterial hypertension in systemic sclerosis: from classical treatments to new horizons.”

healthcare resource utilization and medical costs in pulmonary arterial hypertension management in japan a retrospective study using a claims database

Original title: “Healthcare Resource Utilization and Medical Costs in Pulmonary Arterial Hypertension Management in Japan: A Retrospective Study Using a Claims Database.”

large animal model of heritable pulmonary arterial hypertension using gene edited bmpr2 sheep

Original title: “A Large Animal Model of Heritable Pulmonary Arterial Hypertension Using Gene-edited BMPR2 Sheep.”

Follow along as BioSpace tracks job cuts and restructuring initiatives.

Original title: “GSK Puts up to 350 US, UK Jobs on the Chopping Block”